Somatuline Autogel 120 mg

Somatuline Autogel 120 mg is a subcutaneous solution for extended-release administration. It contains lanreotide acetate, used for managing symptoms related to certain hormonal conditions. This medication is designed for long-term management and is administered via injection.

Somatuline Autogel 120 mg is primarily used for the management of symptoms associated with conditions like acromegaly and neuroendocrine tumors. Lanreotide acetate works by regulating hormone levels in the body. It is often prescribed to control symptoms such as excessive growth hormone production or tumor-related hormonal imbalances. Patients may wonder, 'What is Somatuline Autogel used for?' It is typically used to alleviate symptoms and improve quality of life in these conditions.

Common effects of Somatuline Autogel 120 mg may include injection site reactions, gastrointestinal discomfort, and mild headaches. Some users may experience fatigue or dizziness. These effects are generally mild and temporary. However, any persistent or severe symptoms should be discussed with a healthcare provider.

Somatuline Autogel 120 mg should be handled with care to avoid contamination. It is important to follow proper injection techniques and dispose of used syringes safely. Patients with a history of gallbladder disease or diabetes should use this medication under medical supervision. Always store the medication as directed to maintain its efficacy.

Somatuline Autogel 120 mg may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be moderated, as it can exacerbate side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. CYP inhibitors and other drugs that affect liver enzymes may require dose adjustments.